CollPlant Biotechnologies Ltd.

NasdaqGM:CLGN 株式レポート

時価総額:US$48.8m

CollPlant Biotechnologies マネジメント

マネジメント 基準チェック /34

CollPlant Biotechnologiesの CEO はYehiel Talで、 Jan2010年に任命され、 の在任期間は 14.83年です。 の年間総報酬は$ 1.08Mで、 50.3%給与と49.7%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.27%を直接所有しており、その価値は$ 132.57K 。経営陣と取締役会の平均在任期間はそれぞれ8.3年と4.8年です。

主要情報

Yehiel Tal

最高経営責任者

US$1.1m

報酬総額

CEO給与比率50.3%
CEO在任期間14.8yrs
CEOの所有権0.3%
経営陣の平均在職期間8.3yrs
取締役会の平均在任期間4.8yrs

経営陣の近況

Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation

Jul 29
Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation

Recent updates

We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow

Aug 20
We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow

We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow

Feb 03
We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow

Is CollPlant Biotechnologies (NASDAQ:CLGN) In A Good Position To Deliver On Growth Plans?

Nov 02
Is CollPlant Biotechnologies (NASDAQ:CLGN) In A Good Position To Deliver On Growth Plans?

CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shares Lagging The Industry But So Is The Business

Sep 06
CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shares Lagging The Industry But So Is The Business

Here's Why We're Watching CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Jul 14
Here's Why We're Watching CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Here's Why We're Not Too Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Mar 02
Here's Why We're Not Too Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation

Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Are In A Position To Invest In Growth

Nov 10
Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Are In A Position To Invest In Growth

CollPlant Non-GAAP EPS of -$0.36, revenue of $0.07M

Aug 25

We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth

Jul 22
We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 22
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

CollPlant Biotechnologies - A Cheap, Game-Changing Bio-Printing Platform Company

Aug 05

Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation

Jul 29
Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation

The Strong Earnings Posted By CollPlant Biotechnologies (NASDAQ:CLGN) Are A Good Indication Of The Strength Of The Business

Jun 09
The Strong Earnings Posted By CollPlant Biotechnologies (NASDAQ:CLGN) Are A Good Indication Of The Strength Of The Business

CEO報酬分析

CollPlant Biotechnologies の収益と比較して、Yehiel Tal の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$17m

Mar 31 2024n/an/a

-US$7m

Dec 31 2023US$1mUS$541k

-US$7m

Sep 30 2023n/an/a

-US$7m

Jun 30 2023n/an/a

-US$7m

Mar 31 2023n/an/a

-US$17m

Dec 31 2022US$1mUS$689k

-US$17m

Sep 30 2022n/an/a

-US$16m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$14m

Dec 31 2021US$1mUS$422k

US$237k

Sep 30 2021n/an/a

US$1m

Jun 30 2021n/an/a

US$5m

Mar 31 2021n/an/a

US$6m

Dec 31 2020US$761kUS$391k

-US$6m

Sep 30 2020n/an/a

-US$7m

Jun 30 2020n/an/a

-US$11m

Mar 31 2020n/an/a

-US$11m

Dec 31 2019US$784kUS$395k

-US$11m

Sep 30 2019n/an/a

-US$6m

Jun 30 2019n/an/a

-US$6m

Mar 31 2019n/an/a

-US$4m

Dec 31 2018n/an/a

-US$6m

Sep 30 2018n/an/a

-US$6m

Jun 30 2018n/an/a

-US$6m

Mar 31 2018n/an/a

-US$7m

Dec 31 2017US$441kUS$247k

-US$6m

報酬と市場: Yehielの 総報酬 ($USD 1.08M ) は、 US市場 ($USD 647.72K ) の同規模の企業の平均を上回っています。

報酬と収益: Yehielの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Yehiel Tal (72 yo)

14.8yrs

在職期間

US$1,076,000

報酬

Mr. Yehiel Tal has been the Chief Executive Officer of CollPlant Biotechnologies Ltd. (formerly known as CollPlant Holdings Ltd.) since January 2010 and also serves as its Director since May 2022. Mr. Tal...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Yehiel Tal
CEO & Director14.8yrsUS$1.08m0.27%
$ 132.6k
Eran Rotem
Deputy CEO & CFO12.8yrsUS$748.00kデータなし
Oren Fahimipoor
Vice President of Operations1.6yrsUS$323.00kデータなし
Elana Gazal
Vice President of Research & Development2yrsUS$379.00kデータなし
Oded Shoseyov
Founder & Chief Scientist20.8yrsUS$252.97kデータなし
Hadas Horowitz
Vice President of Human Resources3.7yrsデータなしデータなし

8.3yrs

平均在職期間

52.5yo

平均年齢

経験豊富な経営陣: CLGNの経営陣は経験豊富で経験豊富です(平均在職期間は8.3年)。


取締役

名称ポジション在職期間報酬所有権
Yehiel Tal
CEO & Director2.5yrsUS$1.08m0.27%
$ 132.6k
Abraham Havron
Independent Director8.5yrsデータなしデータなし
Elan Penn
Independent Director6.8yrsデータなしデータなし
Roger Pomerantz
Independent Chairman of the Board4.8yrsデータなしデータなし
Hugh Evans
Independent Director3.7yrsデータなし3.3%
$ 1.6m
Ofer Levy
Member of the Scientific Advisory Board & Member of the Clinical Advisory Boardno dataデータなしデータなし
Joseph Zarzewsky
Independent Director5.3yrsデータなしデータなし
Alisa Lask
Independent Director3.3yrsデータなしデータなし
Shay Soker
Member of Advisory Board6.4yrsデータなしデータなし
Sachin Shridharani
Member of Advisory Boardless than a yearデータなしデータなし

4.8yrs

平均在職期間

67yo

平均年齢

経験豊富なボード: CLGNの 取締役会経験豊富 であると考えられます ( 4.8年の平均在任期間)。